{
    "industry": "Biotechnology / Pharmaceuticals",
    "company_size": "mid_to_large",
    "current_capabilities": [
        "Traditional small molecule drug discovery",
        "Clinical trial management",
        "Manufacturing and quality control",
        "Regulatory affairs expertise"
    ],
    "strategic_priorities": [
        "Expand into novel therapeutic modalities",
        "Accelerate drug discovery timelines",
        "Develop precision medicine capabilities",
        "Build digital health portfolio"
    ],
    "risk_tolerance": "moderate_to_high",
    "investment_horizon": "5-10 years",
    "constraints": [
        "FDA and regulatory compliance",
        "Long development timelines",
        "High capital requirements",
        "Complex IP landscape"
    ],
    "budget_range": "high"
}
